Ticker > Company >

Sahajanand Medical share price

Sahajanand Medical Technologies Ltd.

  7.13 K   2   0 NSE: SMT BSE: 545001 SECTOR: Medical Equipment/Supplies/Accessories

525.95
+38.20 (7.83%)
NSE: 06 Nov 4:00 PM

Price Summary

Today's High

₹ 531.95

Today's Low

₹ 485.2

52 Week High

₹ 565.75

52 Week Low

₹ 346.65

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 5346.11 Cr.

Enterprise Value

₹ 5540.15 Cr.

No. of Shares

10.16 Cr.

P/E

122.89

P/B

8.18

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  64.34

CASH

₹ 6.47 Cr.

DEBT

₹ 200.51 Cr.

Promoter Holding

36.2 %

EPS (TTM)

₹  4.28

Sales Growth

3.94%

ROE

7.01 %

ROCE

7.54%

Profit Growth

649.4 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3.94%
3 Year8.11%
5 Year6.48%

Profit Growth

1 Year649.4%
3 Year28.04%
5 Year44.06%

ROE%

1 Year7.01%
3 Year0.08%
5 Year0.72%

ROCE %

1 Year7.54%
3 Year3.04%
5 Year4.11%

Debt/Equity

0.3097

Price to Cash Flow

634.47

Interest Cover Ratio

3.7501

CFO/PAT (5 Yr. Avg.)

7.3733503374554

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Oct 2026 36.20 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.19011230789748.
  • The company has an efficient Cash Conversion Cycle of 43.423 days.
  • The company has a good cash flow management; CFO/PAT stands at 7.3733503374554.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 64.6216475258443.

 Limitations

  • The company has shown a poor revenue growth of 8.1083539697822% for the Past 3 years.
  • Company has a poor ROE of 0.0845999999999997% over the past 3 years.
  • Company has a poor ROCE of 3.04256666666667% over the past 3 years
  • The company is trading at a high EV/EBITDA of 66.0537.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2026
Net Sales 158.58
Total Expenditure 138.18
Operating Profit 20.41
Other Income 1.95
Interest 4.23
Depreciation 5.07
Exceptional Items 0
Profit Before Tax 13.05
Tax 3.22
Profit After Tax 9.83
Adjusted EPS (Rs) 1

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 439.44 436.24 474.21 530.29 551.2
Total Expenditure 404.61 379.4 453.08 502.68 485.7
Operating Profit 34.83 56.84 21.12 27.6 65.5
Other Income 11.38 12.56 4.12 11 18.48
Interest 5.45 17.72 8.5 10.37 16.74
Depreciation 13.18 17.51 20.6 16.5 21.19
Exceptional Items -14.97 0 0 -15.03 0
Profit Before Tax 12.61 34.17 -3.87 -3.3 46.05
Tax 13.53 13.45 30.59 4.62 2.54
Net Profit -0.91 20.73 -34.46 -7.92 43.5
Adjusted EPS (Rs.) -0.1 2.13 -3.54 -0.81 4.43

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 9.24 9.75 9.75 9.76 9.81
Total Reserves 524.63 678.1 620.89 611.85 667.53
Borrowings 0 0.84 0.68 26.26 25.95
Other N/C liabilities -4.06 -9.9 -7.47 -15.52 -16.08
Current liabilities 162.32 179.04 255.8 348.68 379.7
Total Liabilities 692.12 857.82 879.65 981.03 1066.92
Assets
Net Block 59.57 63.42 99.74 93.58 91.94
Capital WIP 0 1.35 1.83 3.04 1.57
Intangible WIP 0 0 0 0.65 1.49
Investments 74.78 416.56 458.99 498.12 501.53
Loans & Advances 120.7 47.4 11.17 26.25 74.18
Other N/C Assets 5.89 5.87 2.15 1.11 2.46
Current Assets 431.18 323.22 305.77 358.27 393.73
Total Assets 692.12 857.82 879.65 981.03 1066.92
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 12.61 34.17 -3.87 -3.3 46.05
Adjustment 59.49 35.76 38.86 35.84 27.46
Changes in Assets & Liabilities -21.26 18.6 -1.9 -5.74 -58.37
Tax Paid -16.82 -14 -7.47 -15.03 -6.71
Operating Cash Flow 34.02 74.53 25.62 11.77 8.43
Investing Cash Flow -91.01 -197.89 -57.92 -50.77 -52.25
Financing Cash Flow 82.96 94.7 31.27 63.15 13.99
Net Cash Flow 25.97 -28.66 -1.03 24.15 -29.83

Corporate Actions

Investors Details

PARTICULARS Oct 2026%
promoters 36.20
dhirajkumar savjibhai vas... 2.05
jitendra vallabhbhai kota... 0.03
sahajanand technologies p... 0.06
shree hari trust 34.05
PARTICULARS Oct 2026%
investors 63.80
ashish kacholia 1.08
kotak pre-ipo opportuniti... 3.40
llp 0.01
nhpea sparkle holding b.v... 12.78
nippon life india trustee... 1.41
samara capital markets ho... 20.66
smt esop trust 3.46
suresh kumar agarwal 1.08

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Sahajanand Medical Stock Price Analysis and Quick Research Report. Is Sahajanand Medical an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sahajanand Medical. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sahajanand Medical has a PE ratio of 122.894128093091 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sahajanand Medical has ROA of 4.2484% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sahajanand Medical has a Current ratio of 1.037.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sahajanand Medical has a ROE of 7.0078%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Sahajanand Medical has a Debt to Equity ratio of 0.3097 which means that the company has low proportion of debt in its capital.

  • Sales growth: Sahajanand Medical has reported revenue growth of 3.943% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Sahajanand Medical for the current financial year is 11.8831051023592%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sahajanand Medical is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sahajanand Medical is Rs 4.2797. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sahajanand Medical in Ticker for free. Also, one can get the intrinsic value of Sahajanand Medical by using Valuation Calculators, which are available with a Finology ONE subscription. 

Sahajanand Medical FAQs

Q1. What is Sahajanand Medical share price today?
Ans: The current share price of Sahajanand Medical is Rs 525.95.

Q2. What is the market capitalisation of Sahajanand Medical?
Ans: Sahajanand Medical has a market capitalisation of Rs 5346.11228891 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Sahajanand Medical?
Ans: The PE ratio of Sahajanand Medical is 122.894128093091 and the P/B ratio of Sahajanand Medical is 8.1751641017112, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Sahajanand Medical share?
Ans: The 52-week high share price of Sahajanand Medical is Rs 565.75, and the 52-week low share price of Sahajanand Medical is Rs 346.65.

Q5. Does Sahajanand Medical pay dividends?
Ans: Currently, Sahajanand Medical does not pay dividends. Dividend yield of Sahajanand Medical is around 0%.

Q6. What are the face value and book value of Sahajanand Medical shares?
Ans: The face value of Sahajanand Medical shares is Rs 1, while the book value per share of Sahajanand Medical is around Rs 64.3351. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Sahajanand Medical?
Ans: Sahajanand Medical has a total debt of Rs 200.5135 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Sahajanand Medical?
Ans: The ROE of Sahajanand Medical is 7.0078% and ROCE of Sahajanand Medical is 7.5374%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Sahajanand Medical a good buy for the long term?
Ans: The Sahajanand Medical long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Sahajanand Medical undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Sahajanand Medical appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Sahajanand Medical’s financials?
Ans: You can review Sahajanand Medical’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Sahajanand Medical
X